BRIEF-United Therapeutics Corporation Concludes Enrollment Of The Advance Outcomes Study Of Ralinepag

Reuters
Jun 23, 2025
BRIEF-United <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Corporation Concludes Enrollment Of The Advance Outcomes Study Of Ralinepag

June 23 (Reuters) - United Therapeutics Corp UTHR.O:

  • UNITED THERAPEUTICS CORPORATION CONCLUDES ENROLLMENT OF THE ADVANCE OUTCOMES STUDY OF RALINEPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

  • UNITED THERAPEUTICS CORP - ADVANCE OUTCOMES WILL CONTINUE TO ACCRUE CLINICAL WORSENING EVENTS THROUGH END OF 2025

  • UNITED THERAPEUTICS CORP - ADVANCE OUTCOMES TOP-LINE DATA IS EXPECTED IN FIRST HALF OF 2026

Source text: ID:nBw6Gpn6ba

Further company coverage: UTHR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10